Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA(®))

CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (NCT01243424) is an ongoing, randomized trial in subjects with early type 2 diabetes and increased cardiovascular risk or established complications that will determine the long-term cardiovascular impact of linagliptin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diab Vasc Dis Res
Autori principali: Marx, Nikolaus, Rosenstock, Julio, Kahn, Steven E, Zinman, Bernard, Kastelein, John J, Lachin, John M, Espeland, Mark A, Bluhmki, Erich, Mattheus, Michaela, Ryckaert, Bart, Patel, Sanjay, Johansen, Odd Erik, Woerle, Hans-Juergen
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2015
Soggetti:
Clinical Trial Design
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4390606/
https://ncbi.nlm.nih.gov/pubmed/25780262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164115570301
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi